ALLK - Allakos Inc
0.3291
0.000 -0.061%
Share volume: 725,841
Last Updated: 05-14-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.33
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-06-2024 | 03-12-2025 | 05-07-2025 | |
| Assets | ||||||
| Total Assets | 177.312 M | 156.458 M | 124.434 M | 96.601 M | 59.545 M | |
| Current Assets | 147.634 M | 127.926 M | 97.153 M | 85.586 M | 58.089 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 96.192 M | 96.625 M | 82.266 M | 63.067 M | 31.014 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 43.060 M | 26.496 M | 10.449 M | 17.753 M | 24.223 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 17.364 M | 16.590 M | 15.733 M | 10.827 M | 1.456 M | |
| Other Assets | 12.314 M | 11.942 M | 11.548 M | 188.000 K | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 177.312 M | 156.458 M | 124.434 M | 96.601 M | 59.545 M | |
| Total liabilities | 73.329 M | 72.459 M | 51.691 M | 17.784 M | 4.081 M | |
| Total current liabilities | 35.921 M | 35.880 M | 15.981 M | 17.784 M | 0.000 | |
| Accounts Payable | 15.748 M | 16.119 M | 3.964 M | 5.490 M | 77.000 K | |
| Other liabilities | 37.408 M | 36.579 M | 35.710 M | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 37.408 M | 36.579 M | 35.710 M | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 103.983 M | 83.999 M | 72.743 M | 78.817 M | 55.464 M | |
| Common stock | 1.294 B | 1.300 B | 1.307 B | 1.313 B | 1.316 B | |
| Retained earnings | -1.190 B | -1.216 B | -1.235 B | -1.234 B | -1.260 B |